Circulating levels of interleukin 6 soluble receptor and its natural antagonist, sgp130, and the risk of myocardial infarction.


OBJECTIVE To investigate the association between circulating levels of the soluble interleukin 6 receptor (sIL6R) and the soluble gp130 (sgp130) with myocardial infarction (MI) and to explore the potential interaction between sIL6R and sgp130 in this association. METHODS Study population is the Stockholm Heart Epidemiology Program (SHEEP), a population… (More)
DOI: 10.1016/j.atherosclerosis.2015.04.014


3 Figures and Tables


Citations per Year

Citation Velocity: 8

Averaging 8 citations per year over the last 2 years.

Learn more about how we calculate this metric in our FAQ.